| Ki-ras and c-myc oncogene expression measured by coamplification polymerase chain reaction. | None |
| Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78. | None |
| Activation of the proto-oncogene c-myc and c-fos by c-ras: involvement of polyamines. | None |
| Kinetics of hybridization of mRNA of c-myc oncogene with 111In-labeled antisense oligodeoxynucleotide probes by high-pressure liquid chromatography. | None |
| [Amplification of C-myc oncogene in squamous cell carcinoma of the larynx]. | None |
| Effects of denervation on the expression of c-myc proto-oncogene during forelimb regeneration of Xenopus laevis froglets. | None |
| Analysis of DNA aneuploidy and c-myc oncoprotein content of canine plasma cell tumors using flow cytometry. | None |
| Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. | None |
| Induction of stable p53 oncoprotein and of c-myc overexpression in cultured normal human uroepithelium by radiation and N-nitrosodiethanolamine. | None |
| Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. | None |
| Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium. | None |
| The control of chondrocyte differentiation during endochondral bone growth in vivo: changes in TGF-beta and the proto-oncogene c-myc. | None |
| Characterization of the superinduction of the c-myc proto-oncogene in fibroblasts by benzamide derivatives. | None |
| Expression of c-myc, c-Ki-ras and c-Ha-ras oncogene products in peripheral blood mononuclear cells from patients with myasthenia gravis. | None |
| Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. | None |
| Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein. | None |
| Distribution of c-myc oncoprotein in healthy and atherosclerotic human carotid arteries. | None |
| Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point. | None |
| Expression of C-myc p62 oncoprotein in multiple myeloma: an immunohistochemical study of 180 cases. | None |
| The c-myc oncogene in tumor progression. | None |